> Chronic Diseases
> Katherine Vandebelt
Global Vice President, Clinical Innovation, Oracle Health Science
> Douglas Schlichting, RN, PhD
Development Director Immunology Product Development – baricitinib rheumatoid arthritis and COVID-19, Eli Lilly and Company
> David Platt, MD
Vice President, Medical Unit Head
Cardiovascular, Renal & Metabolism Medical Unit, Novartis Pharmaceuticals Corporation
> Dr. Sandi See Tai
VP, Medicine Team Lead for Amyloid, Rare Neuro & Cardiac, Pfizer Global Product Development, Pfizer Inc.
> Sailaja Bhaskar, BPharm, MS, PhD, MBA
Executive Director, Clinical Operations Planning, Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P.
> Eric M Pearlman
Senior Medical Director-Neuroscience, US Medical Affairs, Eli Lilly and Company